Search research articles
Contact Us
Filters
Showing results (121-130 of 129) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 129 results.
The Lancet. Respiratory Medicine
|
January 17, 2014
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Imre Noth, Yingze Zhang, Shwu-Fan Ma, et al.
The European Respiratory Journal
|
December 8, 2025
The transcriptome of CD14<sup>+</sup>CD163<sup>-</sup>HLA-DR<sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary Fibrosis
Theodoros Karampitsakos, Minxue Jia, Bochra Tourki, et al.
Cells
|
April 23, 2022
FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis
Stefan Preisendörfer, Yoshihiro Ishikawa, Elisabeth Hennen, et al.
Nature Communications
|
October 12, 2023
Oncogenic context shapes the fitness landscape of tumor suppression
Lily M Blair, Joseph M Juan, Lafia Sebastian, et al.
Nature Medicine
|
March 15, 2016
Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1
Jean-Sébastien Joyal, Ye Sun, Marin L Gantner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2018
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
L Paré, T Pascual, E Seguí, et al.
The Lancet. Respiratory Medicine
|
September 25, 2017
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Jose D Herazo-Maya, Jiehuan Sun, Philip L Molyneaux, et al.
ESMO Open
|
October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial
E Seguí, F Brasó-Maristany, T Pascual, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 129) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 129 results.
The Lancet. Respiratory Medicine
|
January 17, 2014
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Imre Noth, Yingze Zhang, Shwu-Fan Ma, et al.
The European Respiratory Journal
|
December 8, 2025
The transcriptome of CD14<sup>+</sup>CD163<sup>-</sup>HLA-DR<sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary Fibrosis
Theodoros Karampitsakos, Minxue Jia, Bochra Tourki, et al.
Cells
|
April 23, 2022
FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis
Stefan Preisendörfer, Yoshihiro Ishikawa, Elisabeth Hennen, et al.
Nature Communications
|
October 12, 2023
Oncogenic context shapes the fitness landscape of tumor suppression
Lily M Blair, Joseph M Juan, Lafia Sebastian, et al.
Nature Medicine
|
March 15, 2016
Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1
Jean-Sébastien Joyal, Ye Sun, Marin L Gantner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2018
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
L Paré, T Pascual, E Seguí, et al.
The Lancet. Respiratory Medicine
|
September 25, 2017
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Jose D Herazo-Maya, Jiehuan Sun, Philip L Molyneaux, et al.
ESMO Open
|
October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial
E Seguí, F Brasó-Maristany, T Pascual, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 13